Merck's COVID pill appears effective, but may pose pregnancy risks: FDA
(HealthDay)—Merck's experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administration.